We are live on ! Find out more
IMPL

Impel Pharmaceuticals Inc. Common Stock

Delisted

IMPL was delisted on the 15th of December, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$5.79M
NA
2
NVP Associates
California
$4.31M
5VM
3
5AM Venture Management
California
$4.04M
VC
4
Vivo Capital
California
$4.04M
VP
5
venBio Partners
California
$3.86M
Vanguard Group
6
Vanguard Group
Pennsylvania
$720K
LM
7
Lasry Marc
$572K
DA
8
DCF Advisers
Connecticut
$536K +$137K +57,323 +18%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$216K +$363 +152 +0.1%
LCM
10
Laurion Capital Management
New York
$175K
JGC
11
J. Goldman & Co
New York
$112K -$286K -120,000 -60%
BCM
12
Bridgeway Capital Management
Texas
$88.6K +$71.6K +30,000 +90%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$49.4K
Millennium Management
14
Millennium Management
New York
$41K +$70.2K +29,401 New
State Street
15
State Street
Massachusetts
$35.3K -$29.4K -12,300 -33%
EP
16
EPIQ Partners
Minnesota
$26.1K
BlackRock
17
BlackRock
New York
$25.2K +$1.1K +462 +3%
RJA
18
Raymond James & Associates
Florida
$20.3K
CAPTRUST Financial Advisors
19
CAPTRUST Financial Advisors
North Carolina
$20.2K +$34.4K +14,407 New
BJL
20
Brighton Jones LLC
Washington
$19.8K
Northern Trust
21
Northern Trust
Illinois
$18.5K -$327 -137 -1%
Renaissance Technologies
22
Renaissance Technologies
New York
$17K -$7.4K -3,100 -20%
MP
23
McDonald Partners
Ohio
$16.4K
LC
24
Lindbrook Capital
California
$4.28K
JP Morgan Chase
25
JP Morgan Chase
New York
$4K +$6.44K +2,700 +752%